Angiex, Inc. — Form D/A
Angiex, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2025-09-26. The offering totals $28.4M, of which $22.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-09-26
- Form: D/A
- Accession: 0001710380-25-000005
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $28.4M
- Amount sold: $22.0M
- Remaining: $6.4M
- Investors: 137
- Date of first sale: 2025-07-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-554765
Issuer
- Name: Angiex, Inc.
- CIK: 0001710380
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 150 Cambridge Park Drive, 5th Floor, CAMBRIDGE, MA, 02140
- Phone: 617-576-1753
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Jonathan Adams | Director | Philadelphia, PA |
| Amal Amin | Director | Cambridge, MA |
| Errik Anderson | Director | Cambridge, MA |
| Jason Camm | Director | WALTHAM, MA |
| Iain Dukes | Director | Cambridge, MA |
| Haijing Guo | Director | Cambridge, MA |
| Fabian Hansen | Director | Cambridge, MA |
| Paul Jaminet | Director | Cambridge, MA |
| Tina Neel | Director | Cambridge, MA |
| Paul Jaminet | Executive Officer | Cambridge, MA |
Other filings by this issuer (2)
More